Amicus Therapeutics (FOLD) EBITDA (2010 - 2025)
Amicus Therapeutics (FOLD) EBITDA from Jun 30, 2010 to Dec 31, 2025. The TTM Amicus Therapeutics (FOLD) EBITDA is $40M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Amicus Therapeutics (FOLD) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +20.44% |
Annual EBITDA change of Amicus Therapeutics (FOLD)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | $40M | +20.44% |
| 2024 | $33M | -148.20% |
| 2023 | -$69M | -66.47% |
| 2022 | -$207M | +3.28% |
| 2021 | -$200M | -15.93% |
| 2020 | -$238M | -20.42% |
| 2019 | -$299M | -7.80% |
| 2018 | -$325M | -25.97% |
| 2017 | -$438M | +145.39% |
| 2016 | -$179M | +38.92% |
| 2015 | -$129M | +91.51% |
| 2014 | -$67M | +7.51% |
| 2013 | -$62M | +21.92% |
| 2012 | -$51M | +3.91% |
| 2011 | -$49M | -8.33% |
| 2010 | -$54M | +930.27% |
| 2009 | -$5.22M | -86.73% |
| 2008 | -$39M | -4.42% |
| 2007 | -$41M | -11.16% |
| 2006 | -$46M | +132.05% |
| 2005 | -$20M | +126.67% |
| 2004 | -$8.81M | +30.13% |
| 2003 | -$6.77M | +282.49% |
| 2002 | -$1.77M | N/A |